China Cardiovascular Disease "Red Book" was released | 2 of each 5 cases died of cardiovascular disease

Adhere to the concept of "big hygiene and great health" and advocate the health management of the whole life cycle of the cardiovascular. On June 23, the "China Cardiovascular Health and Disease Report 2021" (hereinafter referred to as the "annual report") launch conference and interpretation training meeting arrived as appointment.

From 2005 to 2021, the "China Cardiovascular Health and Disease Report" for 17 years has never been absent. This year's annual report shows that the incidence and mortality rate of cardiovascular disease in my country still top the list. In 2019, 46.74%and 44.26%of the causes of cardiovascular disease in rural areas and urban and urban areas. Essence The number of cardiovascular diseases is 330 million people, of which 13 million strokes, 11.39 million coronary heart disease, 8.9 million heart failure, 5 million lung heart disease, 4.87 million atrial fibrillation, rheumatoid heart disease 2.5 million, congenital heart disease 2 million, 45.3 million lower limb arterial diseases, and 245 million hypertension, cardiovascular disease prevention and control situation is still strict, and the inflection point has not yet arrived.

The annual report inherited the rigorous and pragmatic genes of the State Cardiovascular Disease Center. The incorporated information was the high -quality domestic research results of the editorial committee experts, which guaranteed the authority of the annual report with a rigorous and objective and scientific attitude. Annual report is not only an information platform for national cardiovascular disease prevention and international exchanges and cooperation, but also an important part of improving China's international status and influence in the field of cardiovascular disease prevention and control. Important reference basis is known as the "red book" in China's cardiovascular field.

The annual report advocates the health management of the whole life cycle of the cardiovascular and improves the awareness of the risk of cardiovascular disease in residents. The annual report emphasized that everyone is the first person in his own health. He pays attention to the control of upstream risk factors such as unhealthy diet and insufficient physical activity, and will prevent cardiovascular disease from the source.

Guest speech

Academician Hu Shengshou, dean of Fuwai Hospital of the Chinese Academy of Medical Sciences, introduced that the annual reports of many Chinese and English magazines in the country have conducted summary and festivals. The annual report is not only hailed as the industry's red book, but also included in the source of information sources of the National Health and Health Commission. It focuses on implementing the grassroots level and prevention of national disease prevention and control. From the hospital to the community. He said that the annual report after the 2019 revised edition conforms to the needs of the times and obtained a good social response. It is hoped that the detailed and scientific and valuable information in the 2021 annual report can promote the spread of the concept of great health and health, and change the situation of cardiovascular disease prevention and control. I hope that it can more stimulate social power, scientific power, and help health Chinese actions.

Academician Hu Shengshou

In 2019, the State Council issued the "Opinions on the Implementation of Action of Healthy China", which incorporated cardiovascular disease prevention and control into a special operation of healthy China and promoted disease -centered transformation to health. The National Cardiovascular Disease Center closes to the relevant requirements of health China. In 2019, the "Annual Report of China Cardiovascular Diseases" was renamed the "China Cardiovascular Health and Disease Report", and it increased the factors of cardiovascular health and the risk factors of cardiovascular disease. , Cardiovascular Disease Community Prevention and other related content. Deputy Director Zhou Yuhui of the Disease Control and Control Bureau of the National Health and Health Commission said that he hopes that the National Cardiovascular Center for Cardiovascular Diseases will continue to unite experts in relevant fields in the country, and through strong publicity and promotion, the annual report information will be widely spread and contribute to the construction of health China.

Deputy Director Zhou Yuhui

The press conference was chaired by Deputy Dean Fan Jing of Fuwai Hospital of the Chinese Academy of Medical Sciences. The meeting was sponsored by the National Cardiovascular Center and Fuwai Hospital of the Chinese Academy of Medical Sciences, and co -organized by the Physician News Agency and China Circular Magazine.

Deputy Dean Fan Jing

Report interpretation

Academician Hu Shengshou:

China ’s original Research Flash Cardiovascular Surgery Field

From 2013 to 2016, 87 cardiac centers in China performed 56776,776 cases of coronary bypass transplantation (CAGB). The overall mortality rate in the hospital fell below 2.1%, and the level of international developed countries. Studies have shown that the coronary bridge surgery that is constantly jumping down in vitro circulation must be slightly better than bridge surgery under non -external circulation.

my country's valve surgical surgical volume has increased significantly, reaching about 80,000 cases each year. It is worth noting that the cause of valve disease is gradually replaced by traditional rheumatoid heart disease. Essence

For the treatment of psychological diseases, intervening in blocking surgery has become the mainstream. The success rate of surgery reached 98.4%, the incidence of severe complications dropped to 0.12%, and the mortality rate was only 0.01%. This technology has been recognized as the safest and most effective method of treating the heart disease. It is proud that the interventional therapy technique of congenital heart disease under the guidance of China's original ultrasound guidance in the field of heart disease is also the mainstream in the intervention therapy of China's entire congenital heart disease. Not only that, this technology has also gone abroad to the world, becoming a typical example of China's technology to the world.

In the past few years, major breakthroughs in the field of cardiovascular surgery include: left -hearted auxiliary devices for artificial hearts, as an effective treatment for treatment of advanced heart disease, began to enter my country's clinical trials. In the stage of China's original research, artificial hearts have entered the stage of clinical research and listing. In this field, China Original is also the same as the world as the world, and has gone at the forefront of the world.

Academician Gao Runlin:

Factors of the five major cardiovascular health changes

Academician Gao Runlin, Fuwai Hospital of the Chinese Academy of Medical Sciences, introduced the influencing factors of cardiovascular health in China from the aspects of tobacco use, changing dietary diet, physical activity and health weight of Chinese residents. Academician Gao Runlin

Academician Gao pointed out that smoking increases the risk of death of cardiovascular disease (CVD), coronary heart disease, stroke, and cardiovascular disease. Although the smoking rate of people at the age of 15 and above in China has decreased, the decline rate is lower than the world, and he emphasizes that the sooner the smoking quit smoking, the better.

In recent years, the dietary structure of Chinese residents has changed a lot. The most significant thing is that the fat supply ratio is on the rise. The rural fat supply ratio exceeds 30%of the recommended upper limit for the first time. Insufficient intake of grains, beans, fruits and vegetables, the dietary structure is still unreasonable.

Studies have found that physical activity is related to the onset of hypertension, that is, the smaller the activity, the higher the incidence of hypertension, and the risk of medium and high -intensity body activity reduces the risk of CVD.

In terms of health weight, in 2013, the overweight and obesity rates under the age of 6 were 8.4% and 3.1%, respectively. Compared with 2002, it increased by 1.9%and 0.4%, respectively. In 2012, China ≥18 years old residents had an overweight rate of 30.1%, and the obesity rate was 11.9%. Compared with 2002, the increase was 7.3%and 4.8%, respectively, and rural growth was higher than cities. Academician Gao emphasized that one of every 3 adults across the country had abdominal obesity, which accumulated a large number of "reserve forces" for cardiovascular disease.

Academician Ge Junbo:

The R & D of medical device enters the stage of high -speed development

Academician Ge Junbo, Affiliated to Fudan University, introduced the progress of cardiovascular basic research and development of medical equipment. He pointed out that high -level cardiovascular basic research in mainland China started since 2005. The influential papers are mainly published in the two major magazines, "Cycling" and "Research". In recent years, domestic high -level cardiovascular basic research has developed rapidly. From 2020 to 2021, there were 48 research papers published by communications authors and main authors from mainland China, including extensive content, including heart and vascular anatomy, development and function, pathogenesis, and other fields.

Academician Ge Junbo

From September 1st, 2020 to August 31, 2021, the State Drug Administration approved a total of 68 medical devices to enter innovative medical device review channels. There were 58 domestic original products, accounting for 85.3%. 31 of the 68 items are cardiovascular products, accounting for 45.6%, indicating that the innovation in the field of cardiovascular is dominant in the field of medical device innovation in my country. Compared with 2019, the National Drug Administration has continued to accelerate the speed of cardiovascular equipment approval, and the proportion of approval of innovative medical devices has increased significantly. At the same time stage.

Academician Han Yaling:

Progress of Chinese Cardiovascular Diseases

Academician Han Yaling of the Northern Theater General Hospital introduced that from 2002 to 2019, the mortality rate of acute myocardial infarction (AMI) was generally rising, with rural growth 3.5 times and urban growth 2.66 times. Since 2005, it has risen rapidly. AMI mortality rates in rural areas exceeded urban areas in 2007, 2009, and 2010, and since 2012, the AMI mortality rates in rural areas have increased significantly, and in 2013, it continued to be higher than the urban level.

Academician Han Yaling

Studies have shown that there are significant differences in the treatment and ending of patients with STEMI (ST section of ST section) in different levels of hospitals in China. Compared with provincial hospitals, STEMI patients in prefecture -level and county -level hospitals have a low proportion of re -irrigation treatment, and the proportion of deaths in the hospital is higher. Regarding the treatment of STEMI patients, Academician Han Yaling pointed out that since 2001, Chinese STEMI patients have increased significantly in the treatment rate of Cross -shaped Aurora (PCI), and the treatment rate of thrombolysis has decreased, and the treatment rate has not increased.

In addition, the data shows that the overall diuretic agent in patients with heart failure in China is not obvious. Rate. The overall usage rate of kidney-vascular tension system blocking agent is on the rise, but due to the advent of vascular tension receptor encephaloninase inhibitors, vascular tensionase converting enzyme inhibitors and vascular tension Ⅱ receptor antagonists The usage rate is reduced.

Academician Gu Dongfeng:

Lifetime intervention can significantly reduce the risk of cardiovascular disease

"The risk factors of cardiovascular disease mainly include: hypertension, hypertrophic, and hyperlipidemia." Academician Gu Dongfeng of Fu Waiwai Hospital of the Chinese Academy of Medical Sciences introduced the progress of the risk factors of cardiovascular disease in China. "It is estimated that the number of normal blood pressure in the country is 435 million, which also means that strengthening blood pressure management is imperative." He pointed out that in recent years, China ≥18 years old adults Growing up, the treatment control rate is increased first and then decreased. This also reflects that the effectiveness of high blood pressure -related science popularization and education has achieved obvious results.

Academician Gu Dongfeng

Blood lipids are still a difficult task, and current doctors pay attention to this. Data show that Chinese residents' total cholesterol, low -density lipoprotein cholesterol, non -high -density lipoprotein cholesterol, and triglyceride levels have shown an upward trend in recent years, and the use of low -doses of life drug intervention is of great significance.

The blood glucose management in the "three high co -tubes" also faces challenges. It is estimated that the number of adult diabetes in mainland China has reached 129.8 million. The lifestyle intervention of the pre -diabetes population across the country is very cost -effective, which can reduce the incidence of cumulative diabetes by 9.53%, and the average life expectancy increases by 0.82 years. Academician Gu Dongfeng said that the good news is that through a positive lifestyle intervention, it can significantly reduce the incidence of diabetes, complications of diabetes, the incidence of cardiovascular and cerebrovascular diseases and all causes of mortality.

Professor Wang Yongjun:

China's cerebrovascular disease prevention and control focuses on rural areas

It is estimated that there are currently 2.8 million new cerebrovascular diseases in my country and more than 20 million patients with cerebrovascular diseases. The number of deaths due to cerebrovascular disease is about 1.77 million per year. Professor Wang Yongjun, Dean of Beijing Tiantan Hospital affiliated to Capital Medical University, introduced that in the past 20 years, the mortality rate of cerebrovascular disease in my country has gradually increased, and rural mortality rates are significantly higher than cities.

Professor Wang Yongjun

For patients with cerebrovascular disease, the main risk factors include hypertension, diabetes, coronary heart disease, and hyperlipidemia. Hypertension is the most important risk factor.

Professor Wang emphasized that although the quality of cerebrovascular disease in my country has increased significantly in recent years, it still faces many challenges. Data show that the venous thrombolysis rate of cerebral vascular disease in my country is 29.3%, and the atrial fibrillation anticoagulant is 46.5%. In addition, among patients with ischemic stroke, 55 ‱ ‱ 内 intracranial arteries are used; 10.3%of patients with cerebral hemorrhage are sculpted; Anever aneurysm clip. Professor Wang pointed out that it can be seen that the popularity of the surgery of cerebrovascular disease in my country is an important task for the future.

Media interaction

In the media questioning session, Academician Hu Shengshou, Academician Gao Runlin, Academician Ge Junbo, Academician Han Yaling, Academician Gu Dongfeng, and Professor Wang Wenzhi further explained the current status and future prospects of cardiovascular and cerebrovascular diseases in my country, scientific research, technology, and equipment in the field of cardiovascular fields, and the cardiovascular field. Innovative achievements, the application of precision prediction and effective prevention and control of cardiovascular disease, and the process of standardized diagnosis and treatment of cerebrovascular disease.

Capture: Liu Zibo

Edit: Huang Jing

- END -